Penile cancer medical trial 'gave me two more years'

This news article highlights the story of Eddie Baker, an 83-year-old man with penile cancer, who participated in a medical trial that combined immunotherapy with the standard chemotherapy treatment. According to the article, the trial gave Baker an additional two years of life. Immunotherapy, a relatively new approach in cancer treatment, works by boosting the body's immune system to fight the disease more effectively. While the article does not provide details on the specific trial or the broader outcomes, it suggests that the combination of immunotherapy and chemotherapy can potentially extend the lifespan of patients with penile cancer, a rare and aggressive form of the disease. The article emphasizes the personal experience of Baker, who expressed gratitude for the extra time he was able to spend with his family as a result of the trial. This highlights the potential impact of such medical advancements on the quality of life for cancer patients.